Trials of long-acting islatravir for HIV treatment and prevention placed on hold
Modelling suggests injectable cabotegravir is far more effective than daily oral PrEP for women
Twice-a-year injected drug shows promise for first-line HIV treatment
Injectable HIV therapy should only be given after a check for innate resistance, French study suggests
Top 5 stories on injectable HIV treatment and prevention from CROI 2021
Injectable HIV medications must be practical and affordable, conference hears
To be cost-effective, injectable PrEP can only cost about $3000 more than US generic oral PrEP
HPTN 083: Injectable PrEP can make breakthrough infections hard to detect
Reformulated islatravir implant should provide PrEP for over a year
